S. Uckert et al., Responses of isolated normal human detrusor muscle to various spasmolytic drugs commonly used in the treatment of the overactive bladder, ARZNEI-FOR, 50(5), 2000, pp. 456-460
The spasmolytic activity of flavoxate (CAS 15301-69-6) and the anticholiner
gic agents oxybutynin (CAS 5633-20-5), tolterodine (CAS 124937-51-5) and tr
ospium chloride (CAS 10405-02-4), all of which are commonly utilized in the
treatment of urinary incontinence, on muscarinic tension and electrically
evoked contractions of isolated human detrusor smooth muscle strips was stu
died using the organ bath technique. Within the concentration ranges tested
(trospium chloride 10(-11)-10(-6) mol/l. flavoxate and oxybutynin 10(-9)-1
0(-5) mol/l, tolterodine 10(-10)-10(-5) mol/l), each drug caused a concentr
ation-dependent relaxation of the tension elicited by muscarinic stimulatio
n and dose-dependently attenuated the contractions induced by electrical fi
eld stimulation (EFS). The effects of trospium chloride and tolterodine on
carbachol-induced muscarinic tension were more pronounced than those of oxy
butynin, while trospium chloride and oxybutynin were most effective in inhi
biting the contractions induced by EFS. Flavoxate was significantly less ef
fective than all other drugs tested. Regardless the individual drug concent
rations needed for maximal efficacy, the potency of oxybutynin and navoxate
to reverse muscarinic tension and attenuate EFS-evoked contractions was al
most comparable while tolterodine and trospium chloride were more effective
in relaxing the muscarinic tension of the detrusor strip preparations than
causing inhibition of EFS-induced contractions. Our results again underlin
e the ratio for the use of nortropane analogues (trospium chloride) and phe
nyl-propylamine cresols (tolterodine) in the treatment of frequency, urgenc
y and urge incontinence secondary to an overactive bladder.